Serum ADAM metallopeptidase domain 12 as a promising diagnostic biomarker for breast and liver cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum ADAM metallopeptidase domain 12 as a promising diagnostic biomarker for breast and liver cancer

Published:2022-10-02 Issue:2 Volume:25 Page:473-481
ISSN:1699-3055
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Wang Hanchu,Wu Huan^ORCID,Chen Yue

Funder

National Natural Science Foundation of China

Basic and Applied Basic Research Foundation of Guangdong Province

Shenzhen Key Medical Discipline Construction Fund

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12094-022-02960-2.pdf

Reference32 articles.

1. Cao M, Li H, Sun D, Chen W. Cancer burden of major cancers in China: a need for sustainable actions. Cancer Commun (Lond). 2020;40:205–10.

2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

3. Li J, Guan X, Fan Z, Ching L-M, Li Y, Wang X, et al. Non-invasive biomarkers for early detection of breast cancer. Cancers (Basel). 2020;12:E2767.

4. Zong J, Fan Z, Zhang Y. Serum tumor markers for early diagnosis of primary hepatocellular carcinoma. J Hepatocell Carcinoma. 2020;7:413–22.

5. Pan Y, Chen H, Yu J. Biomarkers in hepatocellular carcinoma: current status and future perspectives. Biomedicines. 2020;8:E576.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New insight into the role of the ADAM protease family in breast carcinoma progression;Heliyon;2024-02

2. Trans-ancestry epigenome-wide association meta-analysis of DNA methylation with lifetime cannabis use;Molecular Psychiatry;2023-11-07

3. Trans-ancestry epigenome-wide association meta-analysis of DNA methylation with lifetime cannabis use;2022-12-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3